Logo
Search for

Articles in Press

Return to articles in press list

Brain Natriuretic Peptide (BNP) as a Biomarker of Myocardial Ischemia-Reperfusion Injury in Cardiac Transplantation

David R. McIlroy, MD, MClin Epi, FANZCACorresponding Author Informationemail address, Sophie Wallace, BS, MPH, Nicholas Roubos, MBBS, BMedSc

published online 23 July 2010.
Corrected Proof

Objectives

To evaluate brain natriuretic peptide (BNP) as a biomarker of ischemia-reperfusion injury in cardiac transplantation

Design

A prospective cohort study.

Setting

A single academic medical center.

Participants

Adult patients undergoing orthotopic cardiac transplantation (n = 25).

Interventions

None.

Measurements and Main Results

The authors performed serial measurements of BNP and troponin-I in cardiac allograft donors and recipients, determining the relationship between these biomarkers and established risk factors for and measures of early graft dysfunction. Postoperative BNP correlated moderately with allograft ischemic time (ρ = 0.52, p = 0.01), donor BNP (ρ = 0.45, p = 0.03), and donor troponin-I (ρ = 0.49, p = 0.01). Postoperative BNP was higher in patients with persistently elevated inotrope requirements and enabled the early identification of such patients. In contrast, there was no association between postoperative troponin-I and these same parameters.

Conclusions

Postoperative BNP is associated with preimplantation and clinical performance parameters related to allograft ischemia-reperfusion injury at the time of cardiac transplantation, providing preliminary evidence to support its potential use as an ischemia-reperfusion injury biomarker in this context.

 Department of Anesthesiology, Columbia-Presbyterian Medical Center, New York, NY

 Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia

 Department of Cardiothoracic Surgery, Alfred Hospital, Melbourne, Australia

Corresponding Author InformationAddress reprint requests to David R. McIlroy, MD, MClin Epi, FANZCA, Department of Anesthesiology, Columbia-Presbyterian Medical Center, PH5-505, 622 West 168th Street, New York, NY, 10032

 Supported by The Alfred Hospital, Department of Anaesthesia Research Fund.

PII: S1053-0770(10)00210-7

doi:10.1053/j.jvca.2010.05.008